The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sacre, S. M.
Right arrow Articles by Foxwell, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sacre, S. M.
Right arrow Articles by Foxwell, B. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2007, 178: 2148-2154.
Copyright © 2007 by The American Association of Immunologists, Inc.

Selective Use of TRAM in Lipopolysaccharide (LPS) and Lipoteichoic Acid (LTA) Induced NF-{kappa}B Activation and Cytokine Production in Primary Human Cells: TRAM Is an Adaptor for LPS and LTA Signaling1

Sandra M. Sacre, Anna M. C. Lundberg, Evangelos Andreakos, Corinne Taylor, Marc Feldmann and Brian M. Foxwell2

Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, London, United Kingdom

TLR signal via Toll-IL-1R (TIR) homology domain-containing adaptor proteins. One of these adaptors, Toll-IL-1R domain-containing adaptor inducing IFN-beta-related adaptor molecule (TRAM), has been shown to be essential for TLR4 signaling in TRAM–/– mice and cell lines. Previously, we showed that MyD88 or Mal dominant-negative constructs did not inhibit LPS induction of cytokines in primary human M-CSF-derived macrophages. A possible explanation was redundancy of the adaptors during LPS signaling. TRAM is a suitable candidate to compensate for these adaptors. To investigate a potential role for TRAM in LPS signaling in human M-CSF-derived macrophages, we engineered an adenoviral construct expressing dominant-negative TRAM-C117H (AdTRAMdn). Synovial fibroblasts (SF) and human umbilical endothelial cells (HUVECs) were used as a nonmyeloid comparison. AdTRAMdn inhibited LPS-induced signaling in SFs and HUVECs, reducing NF-{kappa}B activation and cytokine production, but did not inhibit LPS signaling in M-CSF-derived human macrophages. Further investigation of other TLR ligands showed that AdTRAMdn was also able to inhibit signaling initiated by lipoteichoic acid, a TLR2 ligand, in SFs and HUVECs and lipoteichoic acid and macrophage-activating lipopeptide 2 signaling was also inhibited in TRAM–/– murine embryonic fibroblasts. We conclude that TRAM is an adaptor protein for both TLR4 and TLR2/6 signaling in SFs, HUVECs, and murine embryonic fibroblasts, but cannot demonstrate a role in human macrophages.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by The Arthritis Research Council.

2 Address correspondence and reprint requests to Prof. Brian M. Foxwell, Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, 1 Aspenlea Road, Hammersmith, London W6 8LH, U.K. E-mail address: b.foxwell{at}imperial.ac.uk

3 Abbreviations used in this paper: LTA, lipoteichoic acid; IRF, IFN regulatory factor; TIR, Toll-IL-1R; Mal, MyD88 adaptor like; TIRAP, TIR domain-containing adaptor protein; TRIF, TIR domain-containing adaptor-inducing IFN-beta; TICAM, TIR-containing adaptor molecule; TRAM, TRIF-related adaptor molecule; SARM, sterile {alpha} and HEAT-Armadillo motif; HUVEC, human umbilical endothelial cell; SF, synovial fibroblast; dn, dominant negative; MEF, murine embryonic fibroblast; MOI, multiplicity of infection; Malp, macrophage-activating lipopeptide; IP-10, IFN-inducible protein 10; WT, wild type.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
S. Kenzel, S. Santos-Sierra, S. D. Deshmukh, I. Moeller, B. Ergin, K. A. Fitzgerald, E. Lien, S. Akira, D. T. Golenbock, and P. Henneke
Role of p38 and Early Growth Response Factor 1 in the Macrophage Response to Group B Streptococcus
Infect. Immun., June 1, 2009; 77(6): 2474 - 2481.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. E. Simmonds, F. V. Lali, T. Smallie, P. L. C. Small, and B. M. Foxwell
Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism
J. Immunol., February 15, 2009; 182(4): 2194 - 2202.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. L. Lloyd-Jones, M. M. Kelly, and P. Kubes
Varying Importance of Soluble and Membrane CD14 in Endothelial Detection of Lipopolysaccharide
J. Immunol., July 15, 2008; 181(2): 1446 - 1453.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
R. E. Simmonds and B. M. Foxwell
Signalling, inflammation and arthritis: NF-{kappa}B and its relevance to arthritis and inflammation
Rheumatology, May 1, 2008; 47(5): 584 - 590.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Lundberg, S. K. Drexler, C. Monaco, L. M. Williams, S. M. Sacre, M. Feldmann, and B. M. Foxwell
Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems
Blood, November 1, 2007; 110(9): 3245 - 3252.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
S. M Sacre, S. K Drexler, E. Andreakos, M. Feldmann, F. M Brennan, and B. M J Foxwell
Could toll-like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissue
Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii81 - iii86.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Tamassia, V. Le Moigne, F. Calzetti, M. Donini, S. Gasperini, T. Ear, A. Cloutier, F. O. Martinez, M. Fabbri, M. Locati, et al.
The MYD88-Independent Pathway Is Not Mobilized in Human Neutrophils Stimulated via TLR4
J. Immunol., June 1, 2007; 178(11): 7344 - 7356.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.